Published April 07, 2022 By Alex Keown BioSpace Jazz Pharmaceuticals continues to advance its efforts toward becoming a leading oncology company via a key licensing deal with Werewolf Therapeutics for […]
UK Variant Not as Lethal as Originally Reported
Antibody-Drug Conjugates (ADCs), Breast Cancer, Brown Fat Cells, Cancer Immunology Research, COVID-19 Deaths, COVID-19 Variant B.1.1.7, Covid-19 Variants, Fat Cells, Harvard Medical School, Hospitalized COVID-19 Patients, Immune Cells, Lancet Infectious Diseases, Lancet Public Health, Massachusetts General Hospital, MD Anderson Cancer Center, Osteosarcoma, SARS-CoV-2 virus, Skin Cancer, T-Cells, The Ohio State University Wexner Medical Center, Tumors, WuhanA new study by researchers at the University College London (UCL) published in Lancet Infectious Diseases finds that although the U.K. variant of SARS-CoV-2 known as B.1.1.7 is more transmissible than the wild-type, original Wuhan strain, it is likely not more deadly.